BioWorld® - Medical Device Daily

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information
EMPLOYEES: 54 employees
HISTORY: Founded in 1956
FACILITIES: Full service cGMP custom manufacturing facility
STOCK-FINANCIAL HISTORY: Privately held
BUSINESS STRATEGY: Develop proprietary separations technology for the life sciences industry
Provide contract manufacturing for pharmaceuticals in a GMP facility
AGREEMENTS: Name Products Content of Agreement Date
Research Corp.
Technologies
chiral stationary phases research agreement 4/93
RESEARCH & DEVELOPMENT: Chiral HPLC columns
IAM column for predicting drug permeability
Custom organic synthesis
Analytical method development
Process research
PRODUCTS ON MARKET: Regisil (BSTFA)
Whelk-O
Pinkerton column
Luciferin
Renessen LLC
520 Lake Cook Road, Suite 220
Deerfield IL 60015, US
Phone: (847) 236-5101; Fax: (847) 236-5146
Web: www.renessen.com
E-mail: info@renessen.com
KEY PERSONNEL: Michael Stern, Ph.D.; CEO
Neal Jakel; Ethanol Project Manager
EMPLOYEES: 50+ employees
HISTORY: Founded in 1999
Joint venture between Cargill Inc. and Monsanto Co.
FACILITIES: Building a pilot plant with higher-value ethanol production at Cargill's Iowa
Bioprocesssing Center campus in Eddyville, Iowa (scheduled to open in
1/07)
STOCK-FINANCIAL HISTORY: Privately held
SUBSIDIARIES/DIVISIONS: Argentina office:
Panamericana
Ramal Pilar. km 49.5
Edificio Bureau
Office 2.2.7 (1629)
Pilar, Buenos Aires, Argentina
Phone: +54 2322.473.821
Fax: +54 2322.473.816
E-mail: argentina@renessen.com
SUBSIDIARY OF: Cargill Inc. and Monsanto Co.
BUSINESS STRATEGY: Develop improved ingredients/inputs for the feed and processing industry
Use biotechnology and breeding to produce corn and soybeans with higher
levels of nutrients (such as oil, protein and amino acids) that are important in
feeding animals and processing grain
Copyright ©2006 AHC Media ® 339